Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Sanders

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of the Acoustical Society of America|April 6, 2013
Nonuniform depth grids in parabolic equation solutionsWilliam M Sanders, Michael D Collins
Journal of Intensive Care Medicine|December 11, 2025
Association of Pulmonary Artery Catheter Utilization with Outcomes in Patients with Cardiogenic Shock: A Retrospective Propensity-Matched StudyShahin Isha, Akshat Banga, Ananya Biswas, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitorsPhilip E J Sanderson, Matthew G Stanton, Bruce D Dorsey, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Journal of Medicinal Chemistry|February 7, 2003
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridinesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of the Acoustical Society of America|April 6, 2013
Nonuniform depth grids in parabolic equation solutionsWilliam M Sanders, Michael D Collins
Journal of Intensive Care Medicine|December 11, 2025
Association of Pulmonary Artery Catheter Utilization with Outcomes in Patients with Cardiogenic Shock: A Retrospective Propensity-Matched StudyShahin Isha, Akshat Banga, Ananya Biswas, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitorsPhilip E J Sanderson, Matthew G Stanton, Bruce D Dorsey, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Journal of Medicinal Chemistry|February 7, 2003
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridinesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Pageof 1